Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol
- Resource Type
- Article
- Source
- The Lancet; January 2022, Vol. 399 Issue: 10323 p447-460, 14p
- Subject
- Language
- ISSN
- 01406736; 1474547X